Here is a press statement from RWC-340B president Shannon Stephenson regarding the recent actions taken by drug manufacturers Lilly, Novartis, Merck, Sanofi, and Astra Zeneca. In the statement, RWC-340B calls…
This week, Kalderos announced that it is launching its new “340B Pay” platform which, if implemented, would fundamentally change how the 340B drug discount program operates – shifting a manufacturer’s…
Earlier this week a third drug manufacturer, Novartis Pharmaceuticals, sent letters to 340B covered entities with contract pharmacy arrangements stating that beginning October 1, 2020, covered entities will be required…
Today, Astra-Zeneca joined other manufacturers in announcing that it would no longer honor all contract pharmacy arrangements. Astra-Zeneca sent letters to 340B covered entities informing them that, effective October 1,…
On July 29, Reps. Doris Matsui (D-CA) and Chris Stewart (R-UT) introduced a bill that would protect 340B hospitals from losing their covered entity status and allow flexibility in how…
The Court of Appeals for District of Columbia Circuit issued a 2-1 decision today upholding Medicare Part B reimbursement cuts for 340B drugs from ASP+6% to ASP-22.5%. The case is…
On Friday, July 24, President Donald Trump signed four Executive Orders designed to lower the cost of prescription drugs. This alert will focus on three Orders that could impact 340B…
Following a recent announcement by drug manufacturer Merck, Sanofi recently sent letters to 340B covered entities with contract pharmacy arrangements to request that they participate in a new web-based platform, 340B…
Washington, D.C. – Shannon Stephenson, president of RWC-340B, said, “The White House Executive Orders related to 340B set a very dangerous precedent at the worst time, when safety net providers…
Merck Requests That Covered Entities Submit Contract Pharmacy Claims to 340B ESP Drug manufacturer Merck recently sent letters to 340B covered entities with contract pharmacy arrangements to request that they…